Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 14, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Vertex Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2025. The correspondence emphasizes that the responsibility for the ac… | Read Filing EDGAR |
| Apr. 1, 2026 | CORRESP | Neutral/Informational | Low | Vertex Pharmaceuticals has submitted a response to the SEC's comment letter regarding their Form 10-K for the fiscal year ended December 31, 2025. The SEC requested more detailed … | Read Filing EDGAR |
| Mar. 18, 2026 | UPLOAD | Concern from SEC | High | The SEC has conducted a limited review of Vertex Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2025, focusing specifically on the financial statements and rela… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.